BGI opening 2012

On March 3, 2011, a new research center--Danish Platform for Large-scale Sequencing and Bioinformaticsis to be funded with DKK 170 million by Danish National Advanced Technology Foundation (DKK 84 million), BGI (DKK 60 million) and other partners. This center aims to support development of cancer vaccines and Danish genome research. There are two projects in this platform: One project is to identify previously unknown pathogens that will lead to the development and patenting of commercial vaccines. The second is to establish a unique catalogue of the millions of variations in Danes' DNA. BGI Europe (an overseas branch of BGI) situated at Copenhagen Bio Science Park (COBIS) will play an important role in the disease prevention and genome research.

The following article is quoted from the news release of University of Copenhagen:
http://news.ku.dk/all_news/2011/2011.3/majorgranttosupportdevelopmentofcancervaccine/